Kyntra Bio (KYNB) Price to Book (2014 - 2026)
Kyntra Bio's (KYNB) quarterly Price to Book came in at 1.01 in Q2 2026, down 858.19% year-over-year from 0.13 in Q2 2025, and down 13.7% quarter-over-quarter from 0.89 in Q1 2026.
Analysis
Kyntra Bio (KYNB) Price to Book (2014 - 2026) Analysis & Trends
Kyntra Bio has disclosed Price to Book across 13 years of filings, most recently posting 1.01 for Q2 2026.
- In Q2 2026, Price to Book fell 858.19% year-over-year to 1.01; the TTM figure through Jun 2026 stood at 1.01 (down 858.19% YoY), while the FY2025 annual figure was 1.18, down 399.41% from the prior year.
- Price to Book came in at 1.01 for Q2 2026 at Kyntra Bio, down from 0.89 in the prior quarter.
- In the past five years, Price to Book ranged from a high of 26.41 in Q3 2022 to a low of 70.34 in Q4 2022.
- Average Price to Book over 5 years is 5.8, with a median of 0.48 recorded in 2023.
- Year-over-year, Price to Book surged 861.86% in 2022 and tumbled 1661.77% in 2025.
- Over 5 years, Price to Book stood at 70.34 in 2022, then jumped by 99.39% to 0.43 in 2023, then soared by 44.76% to 0.24 in 2024, then slumped by 399.41% to 1.18 in 2025, then rose by 14.27% to 1.01 in 2026.
- Per Business Quant data, the three most recent Price to Book figures were 1.01 in Q2 2026, 0.89 in Q1 2026, and 1.18 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.58 Bn | 192.59 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.17 Bn | 176.99 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.59 Bn | 122.74 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.61 Bn | 73.61 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.24 Bn | 55.05 Bn | 1.37 Bn |
| 6 | Moderna | 54.29 Bn | 49.15 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 32.96 Bn | 29.65 Bn | 992.69 Mn |
| 8 | Biogen | 31.94 Bn | 30.66 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.38 Bn | 29.38 Bn | 1.16 Mn |
| 10 | Kyntra Bio | 32.38 Mn | 32.38 Mn | 1.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.01 |
| Mar 31, 2026 | -0.89 |
| Dec 31, 2025 | -1.18 |
| Sep 30, 2025 | -2.91 |
| Jun 30, 2025 | -0.11 |
| Mar 31, 2025 | -0.16 |
| Dec 31, 2024 | -0.24 |
| Sep 30, 2024 | -0.17 |
| Jun 30, 2024 | -0.42 |
| Mar 31, 2024 | -1.13 |
| Dec 31, 2023 | -0.43 |
| Sep 30, 2023 | -0.54 |
| Jun 30, 2023 | -3.24 |
| Mar 31, 2023 | -62.42 |
| Dec 31, 2022 | -70.34 |
| Sep 30, 2022 | 26.41 |
| Jun 30, 2022 | 8.00 |
| Mar 31, 2022 | 6.30 |
| Dec 31, 2021 | 5.72 |
| Sep 30, 2021 | 2.75 |